ARTICLE | Clinical News
RVWF regulatory update
October 4, 2010 7:00 AM UTC
The COMP issued a positive opinion to grant Orphan Drug designation for Baxter's RVWF to treat von Willebrand disease (vWD). The recombinant human von Willebrand factor (vWF) is in Phase I testing fo...